Primary Peritoneal Carcinoma Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 2
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
Ovarian CarcinomaPrimary Peritoneal CarcinomaFallopian Tube Carcinoma
Peking University Cancer Hospital & Institute54 enrolled1 locationNCT06420973
Recruiting
Phase 2
Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Peking University Cancer Hospital & Institute116 enrolled1 locationNCT06141265
Recruiting
Phase 2
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
Primary Peritoneal CarcinomaEpithelial Ovarian CarcinomaFallopian Tube Carcinoma
Peking University Third Hospital75 enrolled1 locationNCT04834544